1477-68-5
基本信息
甲氧酩胺鹽酸鹽
3-甲氧基色胺
甲基多巴胺鹽酸鹽
3-甲氧基色胺鹽酸鹽
3-甲氧基酪胺鹽酸鹽
3-O-甲基多巴胺鹽酸鹽
3-甲氧基-4-羥基苯乙胺
甲醇中甲氧酩胺溶液標準物質
3-甲氧基色胺鹽酸鹽 1ML
3-METHOXYTYRAMINE
RARECHEM AL BW 0216
TIMTEC-BB SBB000426
TIMTEC-BB SBB003882
2-ethyl-d4-aMine HCl
3-METHOXYTYRAMINE HCL
3-O-Methyldopamine HCL
MethoxytyraMine solution
3-Methoxy-p-tyraMine HCl
物理化學性質
安全數(shù)據(jù)
制備方法
報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
2024/11/08 | 17285 | 2-甲氧基-4-(2-氨基乙基)苯酚 3-O-Methyldopamine hydrochloride, 99+%, Thermo Scientific Chemicals | 1477-68-5 | 100mg | 958元 |
2024/11/08 | 17285 | 2-甲氧基-4-(2-氨基乙基)苯酚 3-O-Methyldopamine hydrochloride, 99+%, Thermo Scientific Chemicals | 1477-68-5 | 1g | 4577元 |
2024/11/08 | HY-103638A | 2-甲氧基-4-(2-氨基乙基)苯酚 3-Methoxytyramine | 1477-68-5 | 100mg | 500元 |
常見問題列表
Human Endogenous Metabolite
|
The intensity of the fluorescence developed is in a linear relation to the amount of 3-Methoxytyramine hydrochloride presented in the sample up to at least 1 μg. When a high concentration of dopamine is present in the reaction mixture, there is some reduction in the fluorescence derived from 3-Methoxytyramine hydrochloride.
The extracellular DA metabolite 3-Methoxytyramine hydrochloride (3-MT) induces significant behavioral activation in DDD mice. This activity however, is mostly presented as a set of disorganized abnormal movements that includes tremor, head bobbing, straub tail, grooming and abnormal orofacial movements rather than normal forward activity. No effect is observed when 3-Methoxytyramine hydrochloride is infused at doses below 9 μg, at 9 μg and higher doses 3-Methoxytyramine hydrochloride dose-dependently causes transient behavioral activation with a complex set of behaviors. In particular, transient hyperactivity and stereotypy, sniffing, grooming, rearing and mild abnormal involuntary movements (AIMs) at the level of limbs is observed after infusion of 9 μg of 3-Methoxytyramine hydrochloride. Similar behaviors are also observed after 18 μg of 3-Methoxytyramine hydrochloride with the additional appearance of tremor as well as oral and whole body AIMs.